Atalanta Therapeutics

Developer of RNAi therapeutics to treat neurodegenerative diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2019 groups62 employees language atalantatx.com

Social engagement

Social engagement: 9.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include F-Prime Capital, EQT, Sanofi Ventures.

Investor typeCountShare
Venture capital333%
Private equity111%
Bank & private debt111%
Other / undisclosed444%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

23 May 2025 · Medical Director · Boston

Based on job postings tracked across public sources.

Coming soon